- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 22, 2025 | 9.88M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $10.73M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $11.48M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $5.29M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $5.01M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $64.06M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $75.13M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $203.78M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $215.65M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $257.27M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $262.49M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $582.23M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $589.65M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 10.05M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $3.87M |
| Capex | Q1 2025 · Mar 31, 2024 | $4.57M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$26.09M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $342.61M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $340.36M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.52 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.53 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $11.44M |
| Net Income | Q1 2025 · Mar 31, 2024 | $5.24M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $8.69M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $20.13M |